TGFB1 and prostate adenocarcinoma: A moderate correlation was identified only in the prostate adenocarcinoma group for TGF-β (r = 0.54, p = 0.01) and IL-17 (r = 0.42, p = 0.06) as well as for gastric adenocarcinoma (r = 0.40, p = 0.07) for IL-2 (Fig. 1).